MAPK3 and lung carcinoma: Enrichment of molecular pathways revealed deregulation of “PSD-95-dependent signaling in Huntington’s disease”, “signal transduction ERK1/2 signaling pathway”, and “LKB1 signaling pathway in lung cancer cells” [Figure 2C].